TIAA FSB’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.28M Sell
8,823
-1,592
-15% -$216K ﹤0.01% 291
2023
Q1
$1.35M Sell
10,415
-319
-3% -$40.1K 0.01% 277
2022
Q4
$1.37M Buy
10,734
+1,018
+10% +$118K 0.01% 278
2022
Q3
$1.02M Sell
9,716
-1,164
-11% -$128K ﹤0.01% 306
2022
Q2
$1.14M Sell
10,880
-67
-0.6% -$7.95K ﹤0.01% 303
2022
Q1
$1.4M Sell
10,947
-1,455
-12% -$175K ﹤0.01% 285
2021
Q4
$1.53M Sell
12,402
-453
-4% -$59.3K 0.01% 276
2021
Q3
$1.83M Buy
12,855
+532
+4% +$78.3K 0.01% 265
2021
Q2
$1.92M Sell
12,323
-457
-4% -$74K 0.01% 263
2021
Q1
$1.99M Sell
12,780
-244
-2% -$37.8K 0.01% 252
2020
Q4
$1.95M Buy
+13,024
New +$1.84M 0.01% 249
2018
Q4
Sell
-10,561
Closed -$1.35M 354
2018
Q3
$1.35M Sell
10,561
-2,314
-18% -$275K 0.01% 255
2018
Q2
$1.39M Sell
12,875
-8,647
-40% -$941K 0.01% 246
2018
Q1
$2.28M Sell
21,522
-26,183
-55% -$3.04M 0.01% 219
2017
Q4
$5.59M Sell
47,705
-2,869
-6% -$324K 0.03% 143
2017
Q3
$5.75M Buy
50,574
+329
+0.7% +$38K 0.04% 147
2017
Q2
$6.26M Buy
+50,245
New +$5.96M 0.04% 137

Other funds holding ZBH

TIAA FSB's ZBH Position: Q2 2023 in Review

TIAA FSB reduced its Zimmer Biomet (ZBH) stake by 15% in Q2 2023, selling an estimated $216K and leaving 8,823 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #291.

TIAA FSB first reported a position in ZBH in Q2 2017 and has held it in 17 quarters since. The position peaked at $6.26M in Q2 2017. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • TIAA FSB held 8,823 shares of Zimmer Biomet worth $1.28M as of Q2 2023.
  • TIAA FSB sold 1,592 Zimmer Biomet shares in Q2 2023, an estimated $216K.
  • Zimmer Biomet made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #291 holding.
  • TIAA FSB first reported a position in Zimmer Biomet in Q2 2017 and has held it in 17 quarters since.
  • TIAA FSB's Zimmer Biomet position peaked at $6.26M in Q2 2017.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.